DIN 02015439 — MS CONTIN 15 MG
MS CONTIN is a tablet (extended-release) of Morphine marketed by PURDUE PHARMA. The full Morphine monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02015439
- Brand name
- MS CONTIN
- Active ingredient
- Morphine
- Strength
- 15 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- PURDUE PHARMA
- Health Canada status
- MARKETED
- Drug class
- Opioid analgesic
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Morphine products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 00614491 | DOLORAL SIROP | 1 MG | SYRUP | LABORATOIRE ATLAS INC | MARKETED |
| 00614505 | DOLORAL SIROP | 5 MG | SYRUP | LABORATOIRE ATLAS INC | MARKETED |
| 02242163 | KADIAN | 10 MG | CAPSULE (EXTENDED-RELEASE) | BGP PHARMA ULC | MARKETED |
| 02184451 | KADIAN | 100 MG | CAPSULE (EXTENDED-RELEASE) | BGP PHARMA ULC | MARKETED |
| 02184435 | KADIAN | 20 MG | CAPSULE (EXTENDED-RELEASE) | BGP PHARMA ULC | MARKETED |
| 02559722 | KADIAN | 200 MG | CAPSULE (EXTENDED-RELEASE) | BGP PHARMA ULC | MARKETED |
| 02184443 | KADIAN | 50 MG | CAPSULE (EXTENDED-RELEASE) | BGP PHARMA ULC | MARKETED |
| 02320428 | M-EDIAT | 10 MG | CAPSULE (IMMEDIATE-RELEASE) | ETHYPHARM INC | MARKETED |
| 02320436 | M-EDIAT | 20 MG | CAPSULE (IMMEDIATE-RELEASE) | ETHYPHARM INC | MARKETED |
| 02320444 | M-EDIAT | 30 MG | CAPSULE (IMMEDIATE-RELEASE) | ETHYPHARM INC | MARKETED |
| 02320398 | M-EDIAT | 5 MG | CAPSULE (IMMEDIATE-RELEASE) | ETHYPHARM INC | MARKETED |
| 02019930 | M-ESLON | 10 MG | CAPSULE (EXTENDED-RELEASE) | ETHYPHARM INC | MARKETED |
| 02019965 | M-ESLON | 100 MG | CAPSULE (EXTENDED-RELEASE) | ETHYPHARM INC | MARKETED |
| 02177749 | M-ESLON | 15 MG | CAPSULE (EXTENDED-RELEASE) | ETHYPHARM INC | MARKETED |
| 02177757 | M-ESLON | 200 MG | CAPSULE (EXTENDED-RELEASE) | ETHYPHARM INC | MARKETED |
| 02019949 | M-ESLON | 30 MG | CAPSULE (EXTENDED-RELEASE) | ETHYPHARM INC | MARKETED |
| 02019957 | M-ESLON | 60 MG | CAPSULE (EXTENDED-RELEASE) | ETHYPHARM INC | MARKETED |
| 00617288 | MORPHINE HP 50 | 50 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02021056 | MORPHINE LP EPIDURAL | 0.5 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02021048 | MORPHINE LP EPIDURAL | 1 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 00392588 | MORPHINE SULFATE INJ 10MG/ML USP | 10 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 00392561 | MORPHINE SULFATE INJ 15MG/ML USP | 15 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02500728 | MORPHINE SULFATE INJECTION | 10 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02500736 | MORPHINE SULFATE INJECTION | 15 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02500701 | MORPHINE SULFATE INJECTION | 2 MG | SOLUTION | JAMP PHARMA CORPORATION | MARKETED |
| 02474980 | MORPHINE SULFATE INJECTION BP | 10 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02498278 | MORPHINE SULFATE INJECTION EPIDURAL | 0.5 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02498286 | MORPHINE SULFATE INJECTION EPIDURAL | 1 MG | SOLUTION | STERIMAX INC | MARKETED |
| 02382997 | MORPHINE SULFATE INJECTION SDZ | 10 MG | SOLUTION | SANDOZ CANADA INCORPORATED | MARKETED |
| 02491931 | MORPHINE SULFATE INJECTION USP | 100 MG | SOLUTION | STERINOVA INC. | MARKETED |
| 02242484 | MORPHINE SULFATE INJECTION USP | 2 MG | LIQUID | SANDOZ CANADA INCORPORATED | MARKETED |
| 02482746 | MORPHINE SULFATE INJECTION, USP | 10 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02482681 | MORPHINE SULFATE INJECTION, USP | 2 MG | SOLUTION | FRESENIUS KABI CANADA LTD | MARKETED |
| 02014319 | MS CONTIN | 100 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02014327 | MS CONTIN | 200 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02014297 | MS CONTIN | 30 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02014300 | MS CONTIN | 60 MG | TABLET (EXTENDED-RELEASE) | PURDUE PHARMA | MARKETED |
| 02014211 | MS.IR | 10 MG | TABLET (IMMEDIATE-RELEASE) | PURDUE PHARMA | MARKETED |
| 02014238 | MS.IR | 20 MG | TABLET (IMMEDIATE-RELEASE) | PURDUE PHARMA | MARKETED |
| 02014254 | MS.IR | 30 MG | TABLET (IMMEDIATE-RELEASE) | PURDUE PHARMA | MARKETED |
| 02014203 | MS.IR | 5 MG | TABLET (IMMEDIATE-RELEASE) | PURDUE PHARMA | MARKETED |
| 02549808 | PMS-MORPHINE SULFATE | 10 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02549794 | PMS-MORPHINE SULFATE | 5 MG | TABLET | PHARMASCIENCE INC | MARKETED |
| 02478889 | SANDOZ MORPHINE SR | 100 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02244790 | SANDOZ MORPHINE SR | 15 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02478897 | SANDOZ MORPHINE SR | 200 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02244791 | SANDOZ MORPHINE SR | 30 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 02244792 | SANDOZ MORPHINE SR | 60 MG | TABLET (EXTENDED-RELEASE) | SANDOZ CANADA INCORPORATED | MARKETED |
| 00594644 | STATEX | 10 MG | TABLET | KNIGHT THERAPEUTICS INC. | MARKETED |
| 00594652 | STATEX | 5 MG | TABLET | KNIGHT THERAPEUTICS INC. | MARKETED |
| 02302799 | TEVA-MORPHINE SR | 100 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02302764 | TEVA-MORPHINE SR | 15 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02302802 | TEVA-MORPHINE SR | 200 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02302772 | TEVA-MORPHINE SR | 30 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |
| 02302780 | TEVA-MORPHINE SR | 60 MG | TABLET (EXTENDED-RELEASE) | TEVA CANADA LIMITED | MARKETED |